Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Top of the Hill
Value in a post-Covid world

Posted 23 September 2020

The push for a wider view of value in drug assessments is not new, but in the Age of Covid, it seems more important than ever.

While the value of new drugs and vaccines in Australia has to date been measured by economic and financial indicators such as Quality of Life Year (QALY) calculations and net costs, Covid has brought to the fore the importance of less tangible factors in Australian society's response to a virus.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Special Report
Aust Covid Vaccine Tracker
UPDATES: UNICEF stockpiling one billion syringes
Approvals Action
Shakeup for insulin
New biosim plus hypertension and herpes generics
Top of the Hill
Avoiding the Emperor's mistake
Not everyone is convinced about industry's budget win